Compare Cigna Corp (CI) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Tesla, Inc. — how do they compare? Cigna Corp trades at $300.92 (market cap $80.25B), while Tesla, Inc. trades at $398.16 (market cap $1.49T). The key difference: Tesla, Inc. is far larger — about 18.6× Cigna Corp's market cap, and Cigna Corp pays a 2.06% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| CI | TSLA | |
|---|---|---|
Market Cap | $80.25B | $1.49T |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $489.88 |
52-Week Low | $244.41 | $302.63 |
Enterprise Value | $103.35B | $1.46T |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
Tesla (TSLA) trades at $401.71, up 1.76% on the day, but remains in a bearish technical trend with resistance near $408. The stock shows mixed fundamentals with a high P/E of 363.47 and declining profit margins (3.95% net income margin in 2025), though recent Q1 2026 EPS beat expectations. Cash flow improved to $579M net in 2025, but revenue growth has stalled near $95B. Positive developments include European regulatory approval for self-driving software and a potential cheaper EV launch, per The Motley Fool (April 11, 2026).
Outlook is cautious due to valuation concerns and competitive pressures, but long-term optimism hinges on AI and autonomy breakthroughs. Risks include execution challenges in robotics/energy pivots and volatile sentiment. Analysts are divided with a $409.26 consensus target, suggesting limited upside. Investors should weigh high growth expectations against margin compression and technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
